U.S. Physical [USPH] vs Astrana Health [ASTH] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: U.S. Physical Therapy Inc. wins in 11 metrics, Astrana Health Inc. wins in 9 metrics, with 0 ties. U.S. Physical Therapy Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | U.S. Physical Therapy Inc. | Astrana Health Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 52.65 | 73.30 | U.S. Physical Therapy Inc. |
| Price-to-Book Ratio | 2.37 | 2.12 | Astrana Health Inc. |
| Debt-to-Equity Ratio | 40.92 | 193.10 | U.S. Physical Therapy Inc. |
| PEG Ratio | -0.29 | -0.41 | U.S. Physical Therapy Inc. |
| EV/EBITDA | 16.52 | 14.57 | Astrana Health Inc. |
| Profit Margin (TTM) | 5.12% | 0.71% | U.S. Physical Therapy Inc. |
| Operating Margin (TTM) | 10.95% | 1.85% | U.S. Physical Therapy Inc. |
| EBITDA Margin (TTM) | 10.95% | 1.85% | U.S. Physical Therapy Inc. |
| Return on Equity | 7.59% | 4.49% | U.S. Physical Therapy Inc. |
| Return on Assets (TTM) | 4.25% | 3.43% | U.S. Physical Therapy Inc. |
| Free Cash Flow (TTM) | $60.99M | $104.49M | Astrana Health Inc. |
| Dividend Yield | 2.36% | N/A | N/A |
| 1-Year Return | -14.31% | 51.75% | Astrana Health Inc. |
| Price-to-Sales Ratio (TTM) | 1.47 | 0.59 | Astrana Health Inc. |
| Enterprise Value | $1.70B | $2.10B | Astrana Health Inc. |
| EV/Revenue Ratio | 2.20 | 0.66 | Astrana Health Inc. |
| Gross Profit Margin (TTM) | 19.80% | 10.00% | U.S. Physical Therapy Inc. |
| Revenue per Share (TTM) | $51 | $65 | Astrana Health Inc. |
| Earnings per Share (Diluted) | $1.42 | $0.46 | U.S. Physical Therapy Inc. |
| Beta (Stock Volatility) | 1.35 | 0.77 | Astrana Health Inc. |
| Short % of Float | 8.14% | 8.35% | U.S. Physical Therapy Inc. |
U.S. Physical Therapy Inc. vs Astrana Health Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| U.S. Physical Therapy Inc. | -1.01% | 0.63% | -11.87% | -24.73% | -14.93% | -20.77% |
| Astrana Health Inc. | -0.65% | -4.23% | 5.52% | 40.24% | 61.74% | 46.35% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| U.S. Physical Therapy Inc. | -14.31% | -39.38% | -46.40% | 8.99% | 175.91% | 324.16% |
| Astrana Health Inc. | 51.75% | 11.50% | 1.87% | 585.25% | 637.65% | 637.65% |
Performance & Financial Health Analysis: U.S. Physical Therapy Inc. vs Astrana Health Inc.
| Metric | USPH | ASTH |
|---|---|---|
| Market Information | ||
| Market Cap | $1.12B | $1.88B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 154,051 | 497,178 |
| 90 Day Avg. Volume | 162,204 | 435,283 |
| Last Close | $61.87 | $36.67 |
| 52 Week Range | $58.19 - $93.50 | $18.08 - $39.93 |
| % from 52W High | -33.83% | -8.16% |
| All-Time High | $148.48 (Nov 04, 2019) | $133.23 (Nov 15, 2021) |
| % from All-Time High | -58.33% | -72.48% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.43% |
| Quarterly Earnings Growth | -0.55% | 0.43% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.01% |
| Operating Margin (TTM) | 0.11% | 0.02% |
| Return on Equity (TTM) | 0.08% | 0.04% |
| Debt to Equity (MRQ) | 40.92 | 193.10 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $31.51 | $15.94 |
| Cash per Share (MRQ) | $2.40 | $8.68 |
| Operating Cash Flow (TTM) | $75.06M | $114.60M |
| Levered Free Cash Flow (TTM) | $73.92M | $227.95M |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.36% | N/A |
| Last 12-Month Dividend | $1.81 | N/A |
Valuation & Enterprise Metrics Analysis: U.S. Physical Therapy Inc. vs Astrana Health Inc.
| Metric | USPH (Apr 26, 2026) | ASTH (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 52.65 | 73.30 |
| Forward P/E | 22.57 | 10.50 |
| PEG Ratio | -0.29 | -0.41 |
| Price to Sales (TTM) | 1.47 | 0.59 |
| Price to Book (MRQ) | 2.37 | 2.12 |
| Market Capitalization | ||
| Market Capitalization | $1.12B | $1.88B |
| Enterprise Value | $1.70B | $2.10B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.20 | 0.66 |
| Enterprise to EBITDA | 16.52 | 14.57 |
| Risk & Other Metrics | ||
| Beta | 1.35 | 0.77 |
| Book Value per Share (MRQ) | $31.51 | $15.94 |
Financial Statements Comparison: U.S. Physical Therapy Inc. vs Astrana Health Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | USPH (2025) | ASTH (2025) |
|---|---|---|
| Revenue/Sales | 780.99M | 3.18B |
| Cost of Goods Sold | 631.30M | 2.84B |
| COGS % of Revenue | 80.8% | 89.3% |
| Gross Profit | 149.69M | 341.53M |
| Gross Margin | 19.2% | 10.7% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 80.43M | 78.53M |
| Operating Margin | 10.3% | 2.5% |
| EBITDA | 104.86M | 135.35M |
| EBITDA Margin | 13.4% | 4.3% |
| Pre-Tax Income | 77.81M | 39.61M |
| Pre-Tax Income % of Revenue | 10.0% | 1.2% |
| Income Tax | 19.81M | 15.53M |
| Income Tax % of Revenue | 2.5% | 0.5% |
| Net Income (Profit) | 58.01M | 24.08M |
| Profit Margin | 7.4% | 0.8% |
Balance Sheet & Liquidity Metrics
| Metric | USPH (2025) | ASTH (2025) |
|---|---|---|
| Cash & Equivalents | 35.57M | 429.47M |
| Total Current Assets | 139.99M | 863.31M |
| Total Current Assets % of Revenue | 17.9% | 27.1% |
| Total Current Liabilities | 139.04M | 615.27M |
| Total Current Liabilities % of Revenue | 17.8% | 19.3% |
| Long-Term Debt | 263.17M | 1.02B |
| Long-Term Debt % of Revenue | 33.7% | 32.1% |
| Total Shareholders Equity | 770.20M | 558.33M |
| Retained Earnings | 227.22M | 308.38M |
| Retained Earnings % of Revenue | 29.1% | 9.7% |
| Property, Plant & Equipment | 144.20M | 35.74M |
Cash Flow Statement Comparison
| Metric | USPH (2025) | ASTH (2025) |
|---|---|---|
| Operating Cash Flow | 76.30M | 109.88M |
| Operating Cash Flow % of Revenue | 9.8% | 3.5% |
| Capital Expenditures | -14.07M | -10.11M |
| Free Cash Flow | 60.99M | 104.49M |
| FCF Margin | 7.8% | 3.3% |
| Debt Repayment | -181.44M | -495.29M |
| Common Stock Repurchase | -5.57M | -15.43M |
Short Interest & Institutional Ownership Analysis
| Metric | USPH | ASTH |
|---|---|---|
| Shares Short | 1.03M | 2.68M |
| Short Ratio | 6.06 | 6.86 |
| Short % of Float | 8.14% | 8.35% |
| Shares Outstanding | 15.12M | 48.89M |
| Float Shares | 14.76M | 44.36M |
| % Held by Insiders | 2.40% | 20.32% |
| % Held by Institutions | 108.63% | 52.52% |
| % Held by Public | -11.03% | 27.16% |
Dividend Analysis & Yield Comparison: U.S. Physical Therapy Inc. vs Astrana Health Inc.
| Metric | USPH | ASTH |
|---|---|---|
| Last 12-Month Dividend | $1.81 | N/A |
| Last 12-Month Dividend Yield | 2.36% | N/A |
| 3-Year Avg Annual Dividend | $1.77 | N/A |
| 3-Year Avg Dividend Yield | 0.51% | N/A |
| 3-Year Total Dividends | $5.31 | N/A |
| Ex-Dividend Date | Mar 13, 2026 | N/A |